We are live on ! Find out more
Nicholas Company

Nicholas Company Portfolio holdings

AUM $5.47B Turnover 6.8%
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$4.21B
AUM Growth
+$64.6M
Cap. Flow
-$99.3M
Cap. Flow %
-2.36%
Top 10 Hldgs %
30.14%
Holding
265
New
11
Increased
89
Reduced
79
Closed
19
Avg Time Held
0.9 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
0.8 years

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$36.1M
2
ADT icon
ADT Corp
ADT
+$34.9M
3
PFE icon
Pfizer
PFE
+$27.7M
4
CB icon
Chubb
CB
+$19.3M
5
JCI icon
Johnson Controls International
JCI
+$15.1M

Top Sells

Rank Stock Value
1
LO
LORILLARD INC COM STK
LO
+$79.3M
2
MCRS
MICROS SYSTEMS INC
MCRS
+$73.6M
3
MSI icon
Motorola Solutions
MSI
+$51M
4
BHC icon
Bausch Health
BHC
+$23.5M
5
DTV
DIRECTV COM STK (DE)
DTV
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.03%
2 Consumer Discretionary 15.41%
3 Industrials 15.12%
4 Financials 11.91%
5 Technology 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PM icon
26
Philip Morris
PM
$312B
$61.5M 1.46%
729,970
– –
2013 Q2
4 quarters
MA icon
27
Mastercard
MA
$540B
$54.1M 1.29%
736,125
-300
-0% -$22.3K
2013 Q2
4 quarters
NLSN
28
DELISTED
Nielsen Holdings plc
NLSN
$46.9M 1.11%
968,860
+765
+0.1% +$35.6K
2013 Q3
3 quarters
BCR
29
DELISTED
CR Bard Inc.
BCR
$45.8M 1.09%
320,130
– –
2013 Q2
4 quarters
MTD icon
30
Mettler-Toledo International
MTD
$32.8B
$42M 1%
165,910
– –
2013 Q2
4 quarters
CELG
31
DELISTED
Celgene Corp
CELG
$40.7M 0.97%
+474,120
New +$36.1M
2014 Q2
0 quarters
ADT icon
32
DELISTED
ADT Corp
ADT
$38.1M 0.91%
+1,090,090
New +$34.9M
2014 Q2
0 quarters
SCL icon
33
Stepan Co
SCL
$1.41B
$36.1M 0.86%
682,013
-23,277
-3% -$1.31M
2013 Q2
4 quarters
RMD icon
34
ResMed
RMD
$34.1B
$33.3M 0.79%
658,470
+90,710
+16% +$4.5M
2014 Q1
1 quarter
PAG icon
35
Penske Automotive Group
PAG
$13.9B
$32.7M 0.78%
659,832
-159,578
-19% -$7.28M
2013 Q2
4 quarters
PLKI
36
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
$27.1M 0.65%
621,053
+356,664
+135% +$14.5M
2013 Q4
2 quarters
SENEA icon
37
Seneca Foods Class A
SENEA
$1.19B
$27.1M 0.64%
885,561
– –
2013 Q2
4 quarters
TUP icon
38
DELISTED
Tupperware Brands Corporation
TUP
$26.8M 0.64%
319,665
+540
+0.2% +$45.4K
2013 Q2
4 quarters
VYX icon
39
NCR Voyix
VYX
$1.04B
$26.7M 0.64%
1,241,693
+595,048
+92% +$12M
2013 Q2
4 quarters
CAH icon
40
Cardinal Health
CAH
$58.7B
$26M 0.62%
379,625
+15,310
+4% +$1.04M
2013 Q2
4 quarters
MCHP icon
41
Microchip Technology
MCHP
$40.3B
$23.1M 0.55%
947,360
-2,000
-0.2% -$47.7K
2013 Q2
4 quarters
WTW icon
42
Willis Towers Watson
WTW
$28.8B
$23M 0.55%
200,141
+19,043
+11% +$2.14M
2013 Q2
4 quarters
CNK icon
43
Cinemark Holdings
CNK
$4.46B
$22M 0.52%
621,980
+25,255
+4% +$773K
2013 Q3
3 quarters
OPLN icon
44
Openlane
OPLN
$4.51B
$20.6M 0.49%
1,711,871
+1,216
+0.1% +$14K
2013 Q2
4 quarters
SBH icon
45
Sally Beauty Holdings
SBH
$1.6B
$18.5M 0.44%
735,766
– –
2013 Q2
4 quarters
WMB icon
46
Williams Companies
WMB
$84.7B
$16.6M 0.39%
285,075
-42,675
-13% -$1.98M
2013 Q2
4 quarters
NUS icon
47
Nu Skin
NUS
$254M
$16.3M 0.39%
221,015
+38,135
+21% +$3.01M
2013 Q2
4 quarters
TFX icon
48
Teleflex
TFX
$5.43B
$15.2M 0.36%
144,330
-55
-0% -$5.77K
2013 Q2
4 quarters
FMER
49
DELISTED
FIRSTMERIT CORP
FMER
$15M 0.36%
760,365
+182,210
+32% +$3.57M
2013 Q2
4 quarters
APAM icon
50
Artisan Partners
APAM
$2.33B
$14.5M 0.34%
255,770
+73,095
+40% +$4.18M
2013 Q2
4 quarters
1
2
3 4 5

Similar funds

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EFG International
EFG International Zurich $5.46B AUM
Antipodes Partners
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Exor N.V.
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Voleon Capital Management
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
Glenview Capital Management
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TD Private Client Wealth
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Nicholas Company's Q2 2014 Portfolio in Review

As of Q2 2014, Nicholas Company held 265 positions worth $4.21B, up 1.6% from $4.14B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Nicholas Company's Q2 2014 filing shows 11 new, 89 increased, 79 reduced and 19 closed positions. Its largest new stake was Celgene Corp: 474,120 shares worth $40.7M. The largest sale was LORILLARD INC COM STK, an estimated $79.3M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Nicholas Company's largest Q2 2014 buy was Celgene Corp: 474,120 shares worth $40.7M.
  • Nicholas Company added most to Pfizer in Q2 2014, an estimated $27.7M increase.
  • Nicholas Company's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $23.5M.
  • Nicholas Company fully exited LORILLARD INC COM STK in Q2 2014, selling an estimated $79.3M.
  • Nicholas Company's ten largest holdings make up 30% of its $4.21B portfolio in Q2 2014.
  • Nicholas Company opened 11 new positions and closed 19 in Q2 2014.
  • Nicholas Company's portfolio value rose 1.6% quarter-over-quarter to $4.21B.

Based on Nicholas Company's 13F filing for Q2 2014, filed 14 Aug 2014.